arrow
T

Timothée Bruel

Institut Pasteur
H指数:44
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1

温度依赖性复制和对人冠状病毒HKU1先天免疫的敏感性

2026-07-270
OAAI
Complement augments antibody neutralization of SARS-CoV-2 variants

补体增强抗体对SARS-CoV-2变种的中和作用

2026-07-220
PRE
Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study

新型乌米芬韦衍生物对SARS-CoV-2的增强抗病毒活性:国际协作研究启示

2026-04-060
OA
Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study
2025-12-010
OAAI
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study

Omicron感染者重症患者血清中和功能受损及死亡:来自法国SEVARVIR前瞻性、多中心队列研究的启示

2025-11-260
OAAI
BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals

BA.1突破性感染在仅接种疫苗者与混合免疫力个体中引发不同的抗体和记忆B细胞反应。

2025-02-011
OAAI
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants

Β-变体重组加强疫苗引起包括Omicron变体在内的SARS-CoV-2的广泛交叉反应中和

HELIYON
IF3.6
2024-03-011
OAAI
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
2024-01-233
OA
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
MED
IF11.8
2023-10-018
OAAI
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Omicron亚变体BA.2.75.2,BA.4.6和BQ.1.1对中和抗体的抗性

2023-02-14105
OAAI